Corporate News     01-Jun-22
Natco launches first generic version of Nexavar® (Sorafenib) Tablets in US market
Used in treatment of certain types of cancer
Natco Pharma announced the launch of the first generic version of Nexavar® (Sorafenib) Tablets in 200 mg strength today in the U.S. market. The product will be launched by NATCO's commercial partner Viatris, a global pharmaceutical company.

Sorafenib is prescribed for treatment of unresectable Hepatocellular Carcinoma (HCC), advanced Renal Cell Carcinoma (RCC) and Differentiated Thyroid Carcinoma (DTC).

Nexavar® registered sales of USD 69.7 million for the year ending December 2021 as per industry sales data.

Previous News
  Natco Pharma
 ( Results - Analysis 30-May-23   11:27 )
  Natco Pharma fixes record date for interim dividend
 ( Market Beat - Reports 09-Aug-23   15:22 )
  Natco Pharma fixes record date for interim dividend
 ( Market Beat - Reports 15-Nov-23   11:36 )
  Natco Pharma Ltd leads gainers in 'A' group
 ( Hot Pursuit - 16-Feb-24   12:00 )
  Natco Pharma
 ( Results - Analysis 15-Feb-24   10:36 )
  Natco Pharma Ltd rises for third consecutive session
 ( Hot Pursuit - 02-Nov-21   13:05 )
  Natco Pharma announces closure of buyback of shares
 ( Corporate News - 13-May-23   11:07 )
  Natco Pharma
 ( Results - Analysis 14-Aug-21   19:41 )
  Volumes spurt at Natco Pharma Ltd counter
 ( Hot Pursuit - 31-May-22   14:30 )
  Natco Pharma hits 52-week high as PAT rises 40% YoY in Q4
 ( Hot Pursuit - 28-May-24   10:58 )
  Natco Pharma to conduct board meeting
 ( Corporate News - 03-Nov-20   17:49 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top